Study and patient characteristics
| Author(s) | Publication year | Country | Diagnosis is | Patient characteristics* | |||
| Intervention group† | Control group‡ | ||||||
| Sample size, partition female | Age (mean±SD, range) | Sample size, partition female | Age (mean±SD, range) | ||||
| Capone et al28 | 1980 | USA | Primary malignancy of the female genital organs | 56, 100% | NR§, 20–80 | 41, 100% | 20–80 |
| Maguire et al38 | 1983 | UK | Breast cancer | 75, 100% | NR | 77, 100% | NR |
| Clark and Landis5 | 1989 | USA | Breast cancer | NA | NA | NA | NA |
| Mellette39 | 1989 | USA | Mixed | NA | NA | NA | NA |
| Leitsmann et al37 | 1991 | Germany | Primary malignancy of the female genital organs or breast cancer | 363, 100% | NR, 18–60 | NA | NA |
| Zampini and Ostroff46 | 1993 | USA | Mixed | 714, 77% | NR, 20–59 | NA | NA |
| Berglund et al25–27 | 1993 | Sweden | Mixed (mainly breast cancer 83%) | 30, 99% | 53.2±NR, NR | 30, 99% | 54.2±NR |
| 1994a,b | Mixed (mainly breast cancer 80%) | 98, 96% | 52.5±NR, NR | 101, 97% | 53.9±NR | ||
| Rinehart42 | 1994 | USA | Breast cancer | NA | NA | NA | NA |
| Sherer et al43 | 1997 | USA | Primary malignant brain tumour | 13, 38% | 34.3±10.0, 23–52 | NA | NA |
| Fismen et al31 32 | 2000, 2007 | Norway | Breast cancer | 50, 100% | 49.0±NR, 31–66 | NA | NA |
| Van Weert et al44 45 | 2004 | The Netherlands | Mixed (mainly breast cancer 68%) | 37, 84% | 52.8±6.2, 43–67 | NA | NA |
| 2005 | Mixed (mainly breast cancer 59%) | 81, 84% | 51.6±9.3, NR | NA | NA | ||
| Cimprich et al30 | 2005 | USA | Breast cancer | 25, 100% | 48.0±8, 34–66 | NA | NA |
| Heim and Schwerte33 | 2006 | Germany | Prostate cancer | NA | NA | NA | NA |
| Korstjens et al35 | 2006 | The Netherlands | Mixed (mainly breast cancer 54%) | 658, 78% | 50.6±9.5, 18–75 | NA | NA |
| Nieuwenhuijsen et al41 | 2006 | The Netherlands | Mixed (mainly breast cancer 50%) | 26, 73% | 45.8±6.5, NR | NA | NA |
| Meneses et al40 | 2007 | USA | Breast cancer | 129, 100% | 54.5±11.6, NR¶ | NA | NA |
| Høybye et al34 | 2008 | Denmark | Mixed (mainly breast cancer 55%) | 2174, 84% | 55±NR, 35–76 | NA | NA |
| Korstjens et al36 | 2008 | The Netherlands | Mixed (mainly breast cancer 57%) | Group 1: 71, 80% | 49.9±11.3, NR | NA | NA |
| Group 2: 76, 87% | 47.8±10.5, NR | NA | NA | ||||
| Chan et al29 | 2008 | USA | Mixed | 1201, 53% | 40.1±14.1, NR | NA | NA |
↵* Patient characteristics of the intervention group or control group at baseline before the start of the intervention, unless stated otherwise.
↵† NA, not applicable because only intervention description.
↵‡ NA, not applicable because no control group or no return-to-work outcome variables reported.
↵§ NR, not recorded.
↵¶ Mean age of the control+intervention group.